Dose Levels in Particulate-Containing Formulations Impact Anti-drug Antibody Responses to Murine Monoclonal Antibody in Mice-Reference-Cited by-同舟云学术

Dose Levels in Particulate-Containing Formulations Impact Anti-drug Antibody Responses to Murine Monoclonal Antibody in Mice

Published:2015-05 Issue:5 Volume:104 Page:1610-1621
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Shomali Maliheh,Tanriverdi Sultan,Freitag Angelika J.,Engert Julia,Winter Gerhard,Siedler Michael,Kaymakcalan Zehra,Carpenter John F.,Randolph Theodore W.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference44 articles.

1. Specific inhibition of antibody production. I. Protein overloading paralysis;Dresser;Immunology,1962

2. The dosage requirements for immunological paralysis by soluble proteins;Mitchison;Immunology,1968

3. Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha in normal and transgenic mice;Braun;Pharm Res,1997

4. Tumor necrosis factor inhibitors: Clinical implications of their different immunogenicity profiles;Anderson;Semin Arthritis Rheum,2005

5. Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level aggregation;Hermeling;J Pharm Sci,2006

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of monoclonal antibodies in tablet form: A new approach for local delivery;International Journal of Pharmaceutics;2024-08

2. Infliximab aggregates produced in severe and mild elevated temperature stress conditions induce an extended specific CD4 T-cell response;European Journal of Pharmaceutical Sciences;2024-01

3. Nanoparticulate impurities in the pharmaceutical excipient trehalose induce an early immune response;European Journal of Pharmaceutics and Biopharmaceutics;2023-08

4. Frequency and component analysis of contaminants generated in preparation of anticancer agents using closed system drug transfer devices (CSTDs);Scientific Reports;2022-01-07

5. Subvisible Particles in Solutions of Remicade in Intravenous Saline Activate Immune System Pathways in In Vitro Human Cell Systems;Journal of Pharmaceutical Sciences;2021-08